TrialFrontiers in cellular and infection microbiology2022

Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and

Lucas Sousa Magalhães et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.